Earnings Summary

Celularity Inc’s revenue fell -8.31% since last year same period to $3.79Mn in the Q4 2023. On a quarterly growth basis, Celularity Inc has generated 0% jump in its revenue since last 3-months.

Celularity Inc’s net profit fell -484.2% since last year same period to $-93.88Mn in the Q4 2023. On a quarterly growth basis, Celularity Inc has generated 0% jump in its net profits since last 3-months.

Celularity Inc’s net profit margin fell -519.01% since last year same period to -2479.56% in the Q4 2023. On a quarterly growth basis, Celularity Inc has generated 0% jump in its net profit margins since last 3-months.

Celularity Inc’s earning per share (EPS) estimates for the current quarter stand at -0.14 - a -366.67% fall from last quarter’s estimates.

Celularity Inc’s earning per share (EPS) estimates for the current year stand at -0.14.

Celularity Inc’s earning per share (EPS) fell -108.33% since last year same period to -0.5 in the Q4 2023. This indicates that the Celularity Inc has generated -108.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Celularity Inc’s return on assets (ROA) stands at -0.2.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Celularity Inc’s return on equity (ROE) stands at -1.87.